Daniel L. Milligan

2.0k total citations
24 papers, 1.6k citations indexed

About

Daniel L. Milligan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Daniel L. Milligan has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Daniel L. Milligan's work include Angiogenesis and VEGF in Cancer (7 papers), Chemical Synthesis and Analysis (4 papers) and Bacterial Genetics and Biotechnology (4 papers). Daniel L. Milligan is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Chemical Synthesis and Analysis (4 papers) and Bacterial Genetics and Biotechnology (4 papers). Daniel L. Milligan collaborates with scholars based in United States, Russia and New Zealand. Daniel L. Milligan's co-authors include Daniel E. Koshland, W. G. Scott, Sung‐Hou Kim, Jarmila Jancarik, Edward F. Neuhauser, Michael V. Milburn, Gilbert G. Privé, Joanne I. Yeh, Michael R. Malecki and R.C. Loehr and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Daniel L. Milligan

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel L. Milligan United States	18	1.1k	482	181	176	170	24	1.6k
Guillaume Gotthard France	17	1.0k 0.9×	156 0.3×	82 0.5×	37 0.2×	79 0.5×	37	1.6k
Julien Hiblot Switzerland	22	1.0k 0.9×	98 0.2×	328 1.8×	153 0.9×	83 0.5×	35	1.6k
Hartmut Kayser Germany	21	694 0.6×	203 0.4×	111 0.6×	24 0.1×	69 0.4×	67	1.8k
Marlene DeLuca United States	26	2.2k 2.0×	377 0.8×	49 0.3×	167 0.9×	42 0.2×	50	3.0k
Kazuaki Kitano Japan	16	764 0.7×	170 0.4×	169 0.9×	94 0.5×	18 0.1×	53	1.3k
Rocco Falchetto Switzerland	26	1.2k 1.1×	146 0.3×	80 0.4×	125 0.7×	22 0.1×	47	2.0k
Lei Zheng United States	17	1.3k 1.2×	320 0.7×	61 0.3×	115 0.7×	12 0.1×	42	1.9k
William D. McCubbin Canada	27	1.3k 1.2×	105 0.2×	50 0.3×	46 0.3×	70 0.4×	74	2.0k
Sylvie Luche France	21	1.7k 1.5×	203 0.4×	43 0.2×	48 0.3×	36 0.2×	38	2.5k
Dirk-Jan Slotboom Netherlands	22	1.3k 1.2×	474 1.0×	52 0.3×	72 0.4×	14 0.1×	30	1.9k

Countries citing papers authored by Daniel L. Milligan

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Milligan more than expected).

Fields of papers citing papers by Daniel L. Milligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Milligan. The network helps show where Daniel L. Milligan may publish in the future.

Co-authorship network of co-authors of Daniel L. Milligan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Milligan. A scholar is included among the top collaborators of Daniel L. Milligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Milligan. Daniel L. Milligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duncton, Matthew A. J., Eugene L. Piatnitski Chekler, Wai C. Wong, et al.. (2008). Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. Bioorganic & Medicinal Chemistry. 17(2). 731–740. 34 indexed citations

Kiselyov, Alexander S., Evgueni L. Piatnitski, Daniel L. Milligan, & Xiaohu Ouyang. (2007). 1H‐1,2,4‐Triazol‐3‐yl‐anilines: Novel Potent Inhibitors of Vascular Endothelial Growth Factor Receptors 1 and 2. Chemical Biology & Drug Design. 69(5). 331–337. 6 indexed citations

Kiselyov, Alexander S., Daniel L. Milligan, & Xiaohu Ouyang. (2007). Novel inhibitors of VEGF receptors-1 and -2 based on azole-5-carboxamide templates. Bioorganic & Medicinal Chemistry Letters. 17(13). 3550–3557. 2 indexed citations

Kiselyov, Alexander S., Marina N. Semenova, Victor V. Semenov, & Daniel L. Milligan. (2006). Inhibitors of VEGF receptors-1 and -2 based on the 2-((pyridin-4-yl)ethyl)pyridine template. Bioorganic & Medicinal Chemistry Letters. 16(7). 1913–1919. 9 indexed citations

Kiselyov, Alexander S., Victor V. Semenov, & Daniel L. Milligan. (2006). 4‐(Azolylphenyl)‐phthalazin‐1‐amines: Novel Inhibitors of VEGF Receptors I and II. Chemical Biology & Drug Design. 68(6). 308–313. 13 indexed citations

Smith, Leon M., Wai C. Wong, Alexander S. Kiselyov, et al.. (2006). Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 16(19). 5102–5106. 25 indexed citations

Smith, Leon M., Evgueni L. Piatnitski, Alexander S. Kiselyov, et al.. (2006). Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(6). 1643–1646. 12 indexed citations

Piatnitski, Evgueni L., Matthew A. J. Duncton, Alexander S. Kiselyov, et al.. (2005). Arylphthalazines: Identification of a new phthalazine chemotype as inhibitors of VEGFR kinase. Bioorganic & Medicinal Chemistry Letters. 15(21). 4696–4698. 44 indexed citations

Duncton, Matthew A. J., Evgueni L. Piatnitski, Leon M. Smith, et al.. (2005). Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II. Bioorganic & Medicinal Chemistry Letters. 16(6). 1579–1581. 30 indexed citations

10.

Pan, Weitao, Hu Liu, Yong‐Jiang Xu, et al.. (2005). Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases. Bioorganic & Medicinal Chemistry Letters. 15(24). 5474–5477. 18 indexed citations

11.

Giebel, Lutz B., et al.. (1995). Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry. 34(47). 15430–15435. 173 indexed citations

12.

Scott, W. G., Daniel L. Milligan, Michael V. Milburn, et al.. (1993). Refined Structures of the Ligand-binding Domain of the Aspartate Receptor from Salmonella typhimurium. Journal of Molecular Biology. 232(2). 555–573. 60 indexed citations

13.

Milligan, Daniel L. & Daniel E. Koshland. (1993). Purification and characterization of the periplasmic domain of the aspartate chemoreceptor.. Journal of Biological Chemistry. 268(27). 19991–19997. 63 indexed citations

14.

Jancarik, Jarmila, W. G. Scott, Daniel L. Milligan, Daniel E. Koshland, & Sung‐Hou Kim. (1991). Crystallization and preliminary X-ray diffraction study of the ligand-binding domain of the bacterial chemotaxis-mediating aspartate receptor ofSalmonella typhimurium. Journal of Molecular Biology. 221(1). 31–34. 71 indexed citations

15.

Milligan, Daniel L. & Daniel E. Koshland. (1991). Intrasubunit Signal Transduction by the Aspartate Chemoreceptor. Science. 254(5038). 1651–1654. 73 indexed citations

16.

Milburn, Michael V., Gilbert G. Privé, Daniel L. Milligan, et al.. (1991). Three-Dimensional Structures of the Ligand-Binding Domain of the Bacterial Aspartate Receptor with and Without a Ligand. Science. 254(5036). 1342–1347. 353 indexed citations

17.

Milligan, Daniel L. & Daniel E. Koshland. (1990). The amino terminus of the aspartate chemoreceptor is formylmethionine.. Journal of Biological Chemistry. 265(8). 4455–4460. 26 indexed citations

18.

Milligan, Daniel L., John G. Babish, & Edward F. Neuhauser. (1986). Noninducibility of cytochrome P-450 in the earthworm Dendrobaena veneta. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 85(1). 85–87. 24 indexed citations

19.

Neuhauser, Edward F., R.C. Loehr, Daniel L. Milligan, & Michael R. Malecki. (1985). Toxicity of metals to the earthworm Eisenia fetida. Biology and Fertility of Soils. 1(3). 149–152. 141 indexed citations

20.

Neuhauser, Edward F., R.C. Loehr, Michael R. Malecki, Daniel L. Milligan, & Patrick R. Durkin. (1985). The Toxicity of Selected Organic Chemicals to the Earthworm Eisenia fetida. Journal of Environmental Quality. 14(3). 383–388. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact